MMC
60
6
EMN
56
7
NTRS
57
2
HPE
61
6
BXP
52
2
FE
52
3
HBAN
56
2
ILMN
37
5
XRX
41
6
HSIC
51
-3
V
66
6
APA
24
3
PFG
42
3
UA
59
14
SEE
52
6
BMY
58
5
RRC
59
-4
PVH
57
5
ALL
51
8
CVS
50
2
MMC
60
6
EMN
56
7
NTRS
57
2
HPE
61
6
BXP
52
2
FE
52
3
HBAN
56
2
ILMN
37
5
XRX
41
6
HSIC
51
-3
V
66
6
APA
24
3
PFG
42
3
UA
59
14
SEE
52
6
BMY
58
5
RRC
59
-4
PVH
57
5
ALL
51
8
CVS
50
2
Financhill
Back

Atlas Copco AB 10K Form

Sell
39

ATLKY
Atlas Copco AB

Last Price:
15.58
Seasonality Move:
4.04%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ATLKY News And Ratings

See the #1 stock for the next 7 days that we like better than ATLKY

ATLKY Financial Statistics

Sales & Book Value

Annual Sales: $16.31B
Cash Flow: $733.53M
Price / Cash Flow: 26.55
Annual Sales: $2.08
Price / Book: 7.49

Profitability

EPS (TTM): 0.56150
Net Income (TTM): $2.74B
Gross Margin: $7.1B
Return on Equity: 29.27%
Return on Assets: 14.7%

Atlas Copco AB Earnings Forecast

Key Atlas Copco AB Financial Ratios

  • The Gross Profit Margin over the past 19 years for ATLKY is 43.50%.
  • The Selling, General & Administrative Expenses for ATLKY have been equal to 17.40% of Gross Profit Margin.
  • The Research & Development expenses have been 3.88% of Revenue.
  • The Interest Expense is 3.26% of Operating Income.
  • The Net Earning history of ATLKY is 16.24% of Total Revenues.
  • Per Share Earnings over the last 19 years have been positive in 11 years.

Atlas Copco AB Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Machinery
Sector: Industrials
Current Symbol: ATLKY
Website: atlascopcogroup.com

Debt

Debt-to-Equity Ratio: 0.33
Current Ratio: 1.56
Quick Ratio: 1.08

Price-to-Earnings

Trailing P/E Ratio: 28.69
Forward P/E Ratio: 0

ATLKY Technical Analysis vs Fundamental Analysis

Sell
39
Atlas Copco AB (ATLKY) is a Sell

Is Atlas Copco AB a Buy or a Sell?

  • Atlas Copco AB stock is rated a Sell
    The current Atlas Copco AB [ATLKY] share price is $15.58. The Score for ATLKY is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.